SMC Radiation Oncology SABR Cohort for Oligometastasis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SMC Radiation Oncology SABR Cohort for Oligometastasis — Stella

Home/Stereotactic Body Radiation Therapy (SBRT)/

View on ClinicalTrials.gov

Recruiting

Back to Stereotactic Body Radiation Therapy (SBRT) trials

Trial locations(1 site)

South Korea

Samsung medical center, Seoul

Key details

Sponsor

Samsung Medical Center

Enrollment target

~60 participants

Started

May 2025

Primary completion

December 2027

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.